Stay updated on PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial
Sign up to get notified when there's something new on the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page.

Latest updates to the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check77 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the detailed description of a Phase 3 clinical trial for PH94B nasal spray aimed at treating social anxiety disorder. The only notable addition is the mention of the revision number, which does not alter the core information.SummaryDifference42%
- Check84 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page.